arrow
C

Chun-Che Liao

academia sinica - taiwan
H指数:16
被引数:749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
2024-05-221
OA
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
2023-11-014
OAAI
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin

天然岩藻多糖通过靶向病毒刺突蛋白和宿主细胞弗林蛋白酶抑制冠状病毒

2023-09-018
PRE
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion
2023-01-178
OAAI
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
2022-12-245
OAAI
A booster dose of Delta x Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

增量剂量的Delta x Omicron杂交mRNA疫苗产生了针对Omicron和其他SARS-CoV-2变体的广泛中和抗体

2022-07-0728
OAAI
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
2022-05-1659
OAAI
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
2022-02-174
OAAI
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
2021-12-01106
OAAI
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
2021-11-0130
OA
Structure-guided antibody cocktail for prevention and treatment of COVID-19
2021-10-2111
OAAI
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
2021-08-1118
OAAI